Literature DB >> 27592628

Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients.

Hideto Chaen1, Shigesumi Kinchiku, Masaaki Miyata, Shoko Kajiya, Hitoshi Uenomachi, Toshinori Yuasa, Kunitsugu Takasaki, Mitsuru Ohishi.   

Abstract

AIM: Low-density lipoprotein cholesterol (LDL-C) is routinely estimated using the Friedewald equation [LDL-C(F)]. A novel method for LDL-C [LDL-C(M)] estimation recently proposed by Martin et al. was reported to be more accurate than the Friedewald formula in subjects in the United States. The validity of LDL-C(M) in different races and patients with diabetes mellitus (DM) has not been elucidated. The purpose of this study was to validate the LDL-C(M) estimates in Japanese population with type 2 DM by comparing with LDL-C(F) and directly measured LDL-C [LDL-C(D)].
METHODS: Both LDL-C(M) and LDL-C(F) levels were compared against LDL-C(D) measured by selective solubilization method in 1,828 Japanese patients with type 2 DM.
RESULTS: On linear regression analysis, LDL-C(M) showed a stronger correlation than that shown by LDL-C(F) (R=0.979 vs. R=0.953, respectively) with LDL-C(D). We further analyzed the effect of serum triglyceride (TG) concentrations on the accuracy of LDL-C(F) and LDL-C(M). Although LDL-C levels showed a positive correlation with TG levels, the LDL-C(F) levels tended to show a greater divergence from LDL-C(D) levels than that shown by LDL-C(M) with changes in TG levels.
CONCLUSION: We for the first time demonstrated a more useful measurement of LDL-C levels estimated by Martin's method than that estimated by the Friedewald equation in Japanese patients with DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27592628      PMCID: PMC5221498          DOI: 10.5551/jat.35972

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  26 in total

1.  Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population.

Authors:  Hirohide Yokokawa; Seiji Yasumura; Kozo Tanno; Masaki Ohsawa; Toshiyuki Onoda; Kazuyoshi Itai; Kiyomi Sakata; Kazuko Kawamura; Fumitaka Tanaka; Yuki Yoshida; Motoyuki Nakamura; Yasuo Terayama; Akira Ogawa; Akira Okayama
Journal:  J Atheroscler Thromb       Date:  2010-10-20       Impact factor: 4.928

2.  Cardiovascular disease in Europe: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

Authors:  Tamio Teramoto; Jun Sasaki; Shun Ishibashi; Sadatoshi Birou; Hiroyuki Daida; Seitaro Dohi; Genshi Egusa; Takafumi Hiro; Kazuhiko Hirobe; Mami Iida; Shinji Kihara; Makoto Kinoshita; Chizuko Maruyama; Takao Ohta; Tomonori Okamura; Shizuya Yamashita; Masayuki Yokode; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2013-12-10       Impact factor: 4.928

5.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

6.  Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study.

Authors:  Makoto Daimon; Toshihide Oizumi; Wataru Kameda; Jun Matsui; Hiroshi Murakami; Yoshiyuki Ueno; Isao Kubota; Hidetoshi Yamashita; Takamasa Kayama; Takeo Kato
Journal:  J Atheroscler Thromb       Date:  2015-05-27       Impact factor: 4.928

7.  A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level.

Authors:  Cameron C Lindsey; Maqual R Graham; Thomas P Johnston; Chelsea G Kiroff; Anna Freshley
Journal:  Pharmacotherapy       Date:  2004-02       Impact factor: 4.705

8.  A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study.

Authors:  D M DeLong; E R DeLong; P D Wood; K Lippel; B M Rifkind
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

9.  Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula.

Authors:  Kyung Ran Jun; Hae-Il Park; Sail Chun; Hyosoon Park; Won-Ki Min
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

10.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

View more
  12 in total

1.  Usefulness of the Martin Method for Estimation of Low-Density Lipoprotein Cholesterol in Coronary Atherosclerosis.

Authors:  Soie Chung
Journal:  Med Princ Pract       Date:  2017-12-04       Impact factor: 1.927

2.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

3.  Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low-density lipoprotein cholesterol in diabetic patients with coronary artery disease.

Authors:  Qiu-Ting Dong; Ying Gao; Na-Qiong Wu; Yuan-Lin Guo; Cheng-Gang Zhu; Sha Li; Hui-Hui Liu; Ye-Xuan Cao; Hui-Wen Zhang; Xi Zhao; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Clin Lab Anal       Date:  2018-01-30       Impact factor: 2.352

4.  Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.

Authors:  Seth S Martin; Robert P Giugliano; Sabina A Murphy; Scott M Wasserman; Evan A Stein; Richard Ceška; José López-Miranda; Borislav Georgiev; Alberto J Lorenzatti; Matti J Tikkanen; Peter S Sever; Anthony C Keech; Terje R Pedersen; Marc S Sabatine
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

5.  Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.

Authors:  Gözde Ertürk Zararsız; Serkan Bolat; Ahu Cephe; Necla Kochan; Serra İlayda Yerlitaş; Halef Okan Doğan; Gökmen Zararsız
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

6.  Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.

Authors:  Takashi Miida; Kunihiro Nishimura; Satoshi Hirayama; Yoshihiro Miyamoto; Masakazu Nakamura; Daisaku Masuda; Shizuya Yamashita; Masaji Ushiyama; Toshiaki Komori; Naohisa Fujita; Shinji Yokoyama; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2017-03-17       Impact factor: 4.928

7.  Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins.

Authors:  Takeshi Sonoda; Takuro Takumi; Masaaki Miyata; Daisuke Kanda; Ippei Kosedo; Satoshi Yoshino; Mitsuru Ohishi
Journal:  J Atheroscler Thromb       Date:  2018-05-23       Impact factor: 4.928

8.  Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.

Authors:  Renato Quispe; Seth Shay Martin; Erin Donelly Michos; Isha Lamba; Roger Scott Blumenthal; Anum Saeed; Joao Lima; Rishi Puri; Sarah Nomura; Michael Tsai; John Wilkins; Christie Mitchell Ballantyne; Stephen Nicholls; Steven Richard Jones; Mohamed Badreldin Elshazly
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

9.  2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders.

Authors:  Bogdan Solnica; Grażyna Sygitowicz; Dariusz Sitkiewicz; Barbara Cybulska; Jacek Jóźwiak; Grażyna Odrowąż-Sypniewska; Maciej Banach
Journal:  Arch Med Sci       Date:  2020-03-02       Impact factor: 3.318

10.  Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.

Authors:  Gurpreet Singh; Yasin Hussain; Zhuoran Xu; Evan Sholle; Kelly Michalak; Kristina Dolan; Benjamin C Lee; Alexander R van Rosendael; Zahra Fatima; Jessica M Peña; Peter W F Wilson; Antonio M Gotto; Leslee J Shaw; Lohendran Baskaran; Subhi J Al'Aref
Journal:  PLoS One       Date:  2020-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.